Cannabinoid-based Drug Discovery and Development Designed to Benefit Cancer Patients

Cannabinoid-based Drug Discovery and Development Designed to Benefit Cancer Patients

0 0 hace 8 meses
This week in The Onco’Zine Brief Peter Hofland, Ph.D talks with Guy Chamberland, M.Sc., Ph.D, about medicinal cannabis.

Chamberland, is a Master Herbalist as well as Chief Executive Officer and Chief Scientific Officer of Tetra Bio-Pharma, a biopharmaceutical company developing cannabinoid-based drugs.

Tetra Bio-Pharma has a clinical development program aimed at bringing novel drugs and treatments to patients and their healthcare providers.

To do this, the Company has several ... Más informaciones

Síguenos en Facebook

iAB member
Copyright 2019 - Spreaker Inc. a Voxnest Company - Crea un podcast - New York, NY
Help